UNIQURE NV's ticker is QURE and the CUSIP is N90064101. A total of 177 filers reported holding UNIQURE NV in Q4 2022. The put-call ratio across all filers is 0.23 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2023 | $209,078 | +22.2% | 30,883 | +21.1% | 0.04% | +8.1% |
| Q3 2023 | $171,065 | -31.0% | 25,494 | +17.8% | 0.04% | -26.0% |
| Q2 2023 | $248,040 | -37.3% | 21,644 | +10.2% | 0.05% | -56.1% |
| Q1 2023 | $395,731 | -20.9% | 19,649 | -11.0% | 0.11% | -76.5% |
| Q4 2022 | $500,259 | +18.3% | 22,067 | -2.1% | 0.48% | +25.0% |
| Q3 2022 | $423,000 | -4.3% | 22,535 | -5.0% | 0.39% | +15.5% |
| Q2 2022 | $442,000 | -10.7% | 23,730 | -13.4% | 0.34% | +44.2% |
| Q1 2022 | $495,000 | -25.6% | 27,388 | -14.5% | 0.23% | -3.7% |
| Q4 2021 | $665,000 | – | 32,041 | – | 0.24% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 155,500 | $11,803,000 | 2.66% |
| Aquilo Capital Management, LLC | 901,490 | $16,290,000 | 2.39% |
| Nantahala Capital Management | 2,811,459 | $50,803,000 | 2.25% |
| Privium Fund Management B.V. | 493,229 | $8,913,000 | 1.97% |
| 683 Capital Management, LLC | 1,355,000 | $24,485,000 | 1.31% |
| Henry James International Management Inc. | 125,622 | $2,270,000 | 0.90% |
| Integral Health Asset Management, LLC | 170,000 | $3,072,000 | 0.80% |
| Nantahala Capital Management | 890,000 | $16,082,000 | 0.71% |
| Sonic Fund II, L.P. | 50,000 | $904,000 | 0.51% |
| Voss Capital, LLC | 70,000 | $1,265,000 | 0.40% |